Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Epidermal growth factor receptor | ||
| Ligand | BDBM525451 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_2229997 (CHEMBL5143769) | ||
| IC50 | 48±n/a nM | ||
| Citation |  Shaikh, M; Shinde, Y; Pawara, R; Noolvi, M; Surana, S; Ahmad, I; Patel, H Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung Cancer. J Med Chem65:1008-1046 (2022) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Epidermal growth factor receptor | |||
| Name: | Epidermal growth factor receptor | ||
| Synonyms: | EGF Receptor Substrate | EGFR | EGFR_HUMAN | ERBB | ERBB1 | Epidermal Growth Factor Receptor Tyrosine Kinase | Epidermal Growth Factor Receptor erbB-1 | Epidermal Growth Factor Receptor, ErbB-1 | Epidermal growth factor receptor (EGFR) | Epidermal growth factor receptor (HER1) | HER1 | Protein-Tyrosine Kinase Erbb-1 | Proto-oncogene c-ErbB-1 | Receptor tyrosine-protein kinase ErbB-1 | Tyrosine-Protein Kinase ErbB-1 | ||
| Type: | Receptor Kinase Domain | ||
| Mol. Mass.: | 134279.59 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P00533 | ||
| Residue: | 1210 | ||
| Sequence: |
| ||
| BDBM525451 | |||
| n/a | |||
| Name | BDBM525451 | ||
| Synonyms: | US11174245, # I-036 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C23H24N6O2 | ||
| Mol. Mass. | 416.4757 | ||
| SMILES | Cn1cc(cn1)-c1cc(ccn1)C(=O)\N=c1/[nH]c2ccccc2n1[C@H]1CC[C@H](O)CC1 |r,wU:24.27,wD:27.31,(5.75,-2.98,;5.75,-1.44,;4.5,-.53,;4.98,.93,;6.52,.93,;6.99,-.53,;4.21,2.26,;2.67,2.26,;1.9,3.6,;2.67,4.93,;4.21,4.93,;4.98,3.6,;.36,3.6,;-.41,4.93,;-.41,2.26,;-1.95,2.26,;-2.86,3.51,;-4.32,3.03,;-5.66,3.8,;-6.99,3.03,;-6.99,1.49,;-5.66,.72,;-4.32,1.49,;-2.86,1.02,;-2.46,-.47,;-.97,-.87,;-.57,-2.36,;-1.66,-3.44,;-1.27,-4.93,;-3.15,-3.05,;-3.55,-1.56,)| | ||
| Structure | 
| ||